MCT2D at the 2023 American Diabetes Association Scientific Sessions

Members of the MCT2D leadership and coordinating center present at the American Diabetes Association 83rd Scientific Sessions, June 23-26, 2023. 

Unequal Barriers to CGM Implementation

Katherine Khosrovaneh, MPH, data analyst for MCT2D, and lead author, presented an ePoster on behalf of the MCT2D team, Impact of Social Vulnerability on Resources for CGM Initiation across Michigan Primary Care Practices, results from a survey of 169 MCT2D primary care practice providers (link). 

Is Low Carb Enough?

Noa Kim, MSI, Informatics Design Lead, and Katherine also presented qualitative analysis of 375 MCT2D case summaries, on physician perceived benefit of multiple interventions versus low carb dietary education alone in the management of type 2 diabetes (link).

A Presidential Address

Rodica Pop-Busui, MD, PhD, MCT2D endocrinology content expert, delivered the president's address at ADA2023. Dr. Pop-Busui sharing her journey, from growing up in Timisoara, Romania, to coming to the United States nearly 30 years ago for a post doctoral research fellowship at the University of Michigan. She has gone on practice medicine as a board-certified endocrinologist and diabetes specialist, while leading pivotal clinical trials in diabetes care.  Dr. Busui served as lead, co-author, collaborator, and mentor for several ADA sessions, including:
  • LX9211, an Orally-Administered, Non-opioid, AAK1 Inhibitor for Painful Diabetic Peripheral Neuropathy—Results from a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study (link)
  • Social Determinants of Health Predict Diabetic Foot Infection Development (link)
  • Cost and Utilization of Health Care Services for Persons with Diabetes (link)
  • Association between Initial Outpatient Diabetic Foot Ulcers Infection Management Strategy and Hospitalization (link)
Dr. Pop-Busui is the Larry D. Soderquist Professor in Diabetes at the University of Michigan Medical School and President of Medicine and Science at the American Diabetes Association and is a foremost expert in the chronic complications of diabetes, particularly diabetic neuropathy, diabetic foot complications, diabetic kidney disease and cardiovascular disease, and novel technologies.
MCT2D content expert and obesity medicine physician Dr. Dina Hafez Griauzde, MD, MSc, discussed and debated low carb eating patterns in a debate-style session, entitled "Should We Curb the Carbs?" She also authored several presentations:  
  • Weight Status, Longitudinal Weight Change, and Weight Loss Treatment Utilization among Primary Care Patients with Obesity (link)
  • Designing and Testing a Novel Weight Navigation Program to Improve Obesity Treatment in Primary Care Settings (link)

Subscribe to the MCT2D Newsletter

* indicates required
Blue Cross Blue Shield Blue Care Network of Michigan

Support for the Michigan Collaborative on Type 2 Diabetes is provided by Blue Cross Blue Shield of Michigan and Blue Care Network as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs. To learn more about Value Partnerships, visit Although Blue Cross Blue Shield of Michigan and the Michigan Collaborative on Type 2 Diabetes work in partnership, the opinions, beliefs, and viewpoints expressed by MCT2D do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.